Benitec Biopharma Limited EV/Sales

EV/Sales of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.


Highlights and Quick Summary

Current EV/Sales of Benitec Biopharma Limited is 282.24 (as of June 30, 2022)
  • EV/Sales for the quarter ending June 30, 2022 was 282.24 (a -48.34% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -185.72%
  • Annual EV/Sales for 2022 was 282.24 (a -82.32% decrease from previous year)
  • Annual EV/Sales for 2022 was 1596.37 (a -584.85% decrease from previous year)
  • Annual EV/Sales for 2021 was -329.25 (a 15.97% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of Benitec Biopharma Limited

Most recent EV/Salesof BNTC including historical data for past 10 years.

Interactive Chart of EV/Sales of Benitec Biopharma Limited

Benitec Biopharma Limited EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 282.24 546.38 282.24
2021 1509.21 -329.25 -552.47 -329.25
2020 -284.05 -56.88 -91.77 -13.13 -91.77
2019 -2.52 0.0 0.0
2018 0.0
2017 0.0 0.0
2016 0.0 0.0
2015 0.0
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology